tirzepatide and cancer 💊 Weight-loss drug shows cancer-fighting potential Researchers at the University of Michigan discovered that (Mounjaro, Zepbound), already FDA-approved for diabetes obesity, also shrinks breast tumors in obese mice. When Semaglutide and tirzepatide prescriptions for

Carpal Tunnel Syndrome Carpal tunnel syndrome (CTS) is a condition that can develop with the use of growth hormone therapies

This ruling puts immense pressure on medspa owners to navigate a complex and shifting regulatory landscapeall while trying to serve their patients

FDA submission is likely coming in 2026/2027 if the remaining readouts hold up Some other noteworthy drugs in the pipeline: Tirzepatide: The base drug is already approved for diabetes and obesity, but Lilly keeps expanding its label Kisunla (donanemab) for Alzheimer's Eloralintide: amylin receptor agonist heading to phase 3, at ADA it showed 20% weight loss on the amylin pathway alone MORF-057: bit of a wild card, after the $3.2 billion acquisition of Morphic

When NAPQI levels are higher than the livers capacity to neutralize, NAPQI will form protein adducts on the mitochondria of liver cells